Morphine Sulfate Immediate-Release Tablets Shortage

• • Morphine tablet, Ascend, 15 mg, bottle, 100 count, NDC 67877-0670-01
  • Morphine tablet, Ascend, 30 mg, bottle, 100 count, NDC 67877-0671-01
  • Morphine tablet, Hikma, 15 mg, bottle, 100 count, NDC 00054-0235-25
  • Morphine tablet, Hikma, 15 mg, unit-dose blister pack, 100 count, NDC 00054-0235-24
  • Morphine tablet, Hikma, 30 mg, bottle, 100 count, NDC 00054-0236-25
  • Morphine tablet, Hikma, 30 mg, unit-dose blister pack, 100 count, NDC 00054-0236-24
  • Morphine tablet, SpecGX (Mallinckrodt), 15 mg, bottle, 100 count, NDC 00406-5118-01
  • Morphine tablet, SpecGX (Mallinckrodt), 15 mg, unit-dose blister pack, 100 count, NDC 00406-5118-62
  • Morphine tablet, SpecGX (Mallinckrodt), 30 mg, bottle, 100 count, NDC 00406-5119-01
  • Morphine tablet, SpecGX (Mallinckrodt), 30 mg, unit-dose blister pack, 100 count, NDC 00406-5119-62
  • Morphine tablet, Upsher-Smith, 15 mg, bottle, 100 count, NDC 00832-0273-11 - discontinued
  • Morphine tablet, Upsher-Smith, 30 mg, bottle, 100 count, NDC 00832-0274-11 - discontinued

• • Ascend will be relaunching morphine immediate tablets in the next few weeks.
  • Hikma did not provide a reason for the shortage.
  • SpecGX has not provided us with availability information.
  • Upsher-Smith is discontinuing morphine immediate-release tablets.

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Hikma has morphine 15 mg immediate-release tablets in 100 count unit-dose packages on back order and the company estimates a release date in late-June 2025. All other presentations are on allocation.